The Patent Finder

Abbisko Therapeutics Co., Ltd.

Also on record
Records under this name other than the patents Abbisko Therapeutics Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Showing 1 to 2 of 2 · Back to Abbisko Therapeutics Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,180,495Nitrogen heteroaryl derivative having CSF1R inhibitory activity, and preparation method therefor and application thereof
Lapsed on the fee record
Ended Nov 23, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 23, 2025USPTO record
US 11,130,762Azaaryl derivative, preparation method therefor, and application thereof for use in pharmacy
Lapsed on the fee record
Ended Sep 28, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 28, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited